Theravance Biopharma (TBPH) Company Statistics | The Fly

Search...

/

Dashboard

Charting

KPIs

Stock Screener

ETF Screener

Earnings Calendar

Events Calendar

Syndicate

Street Research

Portfolios

Alert Settings

© 2026 The Fly Inc.

The Fly Cast

Press play to listen

©

Theravance Biopharma (TBPH) Company Statistics | The Fly

Theravance Biopharma

· TBPH

Dashboard

Financials

Ratios

Transcripts

Valuation

Statistics

884.176 M

+0.00%

General

Market Cap: $884.18M
Enterprise Value: $701.44M
Shares Outstanding: 51,830,000
Dividend: —
Employees: —
Revenue Per Employee: —

Fundamental Ratios (TTM)

Gross Margin: 89.40%
Operating Margin: 4.46%
Net Profit Margin: 51.58%
FCF Margin: 49.68%
ROA: 11.45%
ROE: 19.40%
ROIC: 0.95%
Current Ratio: 13.54
Debt-to-Equity: 0.13
Revenue Per Employee: —

Valuation (TTM)

P/E: 16.35
PEG: 0.05
P/S: 8.46
P/FCF: 17.03
P/B: 3.05
EV/EBITDA: 10.25

Growth

Rev 1Y: 66.92%

Income Statement (TTM)

Revenue: $104.31M
Gross Margin: 89.40%
Operating Expenses: $88.59M
Operating Income: $4.66M
Net Profit: $53.81M

Balance Sheet

Rev 1Y Fwd Est

-20.61%

Rev 3Y (CAGR)

27.91%

Rev 5Y (CAGR)

8.38%

Rev 10Y (CAGR)

9.82%

EPS 1Y

—

EPS 1Y Fwd Est

40.27%

EPS 3Y (CAGR)

—

EPS 5Y (CAGR)

—

EPS 10Y (CAGR)

—

Cash and Equivalents: $219.77M
Working Capital: $385.9M
Total Assets: $469.77M
Net Debt: -$181.2M
Total Liabilities: $180.07M
Total Equity: $289.71M

Cash Flow Statement (TTM)

Cash Flow from Operations: $51.83M
Cash Flow from Investing: -$107.47M
Cash Flow from Financing: -$2.86M
Free Cash Flow: $51.82M
Capital Expenditures: $8K